Abutalebi J, Rosa PAD, Castro Gonzaga AK, Keim R, Costa A, Perani D (2013) The role of the left putamen in multilingual language production. Brain Lang 125:307–315. https://doi.org/10.1016/j.bandl.2012.03.009
Arnold C, Gehrig J, Gispert S, Seifried C, Kell CA (2014) Pathomechanisms and compensatory efforts related to Parkinsonian speech. NeuroImage Clin 4:82–97. https://doi.org/10.1016/j.nicl.2013.10.016
Berankova D, Janousova E, Mrackova M, Eliasova I, Kostalova M, Skutilova S, Rektorova I (2015) Addenbrooke’s cognitive examination and individual domain cut-off scores for discriminating between different cognitive subtypes of Parkinson’s disease. Parkinson Dis 2015:579417. https://doi.org/10.1155/2015/579417
Brabenec L, Mekyska J, Galaz Z, Rektorova I (2017) Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm 124:303–334. https://doi.org/10.1007/s00702-017-1676-0
Article CAS PubMed Google Scholar
Brabenec L, Klobusiakova P, Barton M, Mekyska J, Galaz Z, Zvoncak V, Kiska T, Mucha J, Smekal Z, Kostalova M, Rektorova I (2019) Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson’s disease. Parkinsonism Relat Disord 61:187–192. https://doi.org/10.1016/j.parkreldis.2018.10.011
Brabenec L, Klobusiakova P, Simko P, Kostalova M, Mekyska J, Rektorova I (2021) Non-invasive brain stimulation for speech in Parkinson’s disease: a randomized controlled trial. Brain Stimul 14(3):571–578. https://doi.org/10.1016/j.brs.2021.03.010
Brown S, Laird AR, Pfordresher PQ, Thelen SM, Turkeltaub P, Liotti M (2009) The somatotopy of speech: phonation and articulation in the human motor cortex. Brain Cogn 70:31–41. https://doi.org/10.1016/j.bandc.2008.12.006
Article PubMed PubMed Central Google Scholar
Cushnie-Sparrow D, Adams S, Abeyesekera A, Pieterman M, Gilmore G, Jog M (2018) Voice quality severity and responsiveness to levodopa in Parkinson’s disease. J Commun Disord 76:1–10. https://doi.org/10.1016/j.jcomdis.2018.07.003
Elfmarková N, Gajdoš M, Mračková M, Mekyska J, Mikl M, Rektorová I (2016) Impact of Parkinson’s disease and levodopa on resting state functional connectivity related to speech prosody control. Parkinsonism Relat Disord 22:S52–S55. https://doi.org/10.1016/j.parkreldis.2015.09.006
Fritsch M, Rangus I, Nolte CH (2022) Thalamic Aphasia: a review. Curr Neurol Neurosci Rep 22:855–865. https://doi.org/10.1007/s11910-022-01242-2
Article PubMed PubMed Central Google Scholar
Frota S, Cruz M, Cardoso R, Guimarães I, Ferreira JJ, Pinto S, Vigário M (2021) (Dys)Prosody in Parkinson’s disease: effects of medication and disease duration on intonation and prosodic phrasing. Brain Sci. https://doi.org/10.3390/brainsci11081100
Article PubMed PubMed Central Google Scholar
Gago MF, Garrett MC, Fonseca MR, Rosas MJ, Simões MF, Vieira S, Botelho F (2009) How do cognitive and axial motor signs correlate in Parkinson’s disease? A 6-year prospective study. J Neurol 256:1655–1662. https://doi.org/10.1007/s00415-009-5174-7
Goberman AM, Blomgren M (2003) Parkinsonian speech disfluencies: effects of l-dopa-related fluctuations. J Fluen Disord 28:55–70. https://doi.org/10.1016/S0094-730X(03)00005-6
Gómez-Vilda P, Mekyska J, Ferrández JM, Palacios-Alonso D, Gómez-Rodellar A, Rodellar-Biarge V, Galaz Z, Smekal Z, Eliasova I, Kostalova M, Rektorova I (2017) Parkinson disease detection from speech articulation neuromechanics. Front Neuroinform. https://doi.org/10.3389/fninf.2017.00056
Article PubMed PubMed Central Google Scholar
Jacquemot C, Bachoud-Lévi A-C (2021) Striatum and language processing: where do we stand? Spec Issue Honour Jacques Mehler Cogn Found Ed 213:104785. https://doi.org/10.1016/j.cognition.2021.104785
Klobusiakova P, Mekyska J, Brabenec L, Galaz Z, Zvoncak V, Mucha J, Rapcsak SZ, Rektorova I (2021) Articulatory network reorganization in Parkinson’s disease as assessed by multimodal MRI and acoustic measures. Parkinsonism Relat Disord 84:122–128. https://doi.org/10.1016/j.parkreldis.2021.02.012
Klostermann F, Ehlen F (2013) Functional roles of the thalamus for language capacities. Front Syst Neurosci. https://doi.org/10.3389/fnsys.2013.00032
Article PubMed PubMed Central Google Scholar
Košálová M, Mráčková M, Mareček R, Beránková D, Eliášová I, Koritakova E, Roubíčková J, Bednarik J, Rektorové I (2013) The 3F test dysarthric profile—normative speach values in Czech. Ceska Slov Neurol Neurochir 76:614–618
Kulisevsky J, García-Sánchez C, Berthier ML, Barbanoj M, Pascual-Sedano B, Gironell A, Estévez-González A (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626. https://doi.org/10.1002/1531-8257(200007)15:4%3c613::AID-MDS1005%3e3.0.CO;2-F
Article CAS PubMed Google Scholar
Liotti M, Ramig LO, Vogel D (2003) Hypophonia in Parkinson’s disease: neural correlates of voice treatment revealed by PET. Neurology 60:432–440
Article CAS PubMed Google Scholar
Maillet A, Krainik A, Debû B, Troprès I, Lagrange C, Thobois S, Pollak P, Pinto S (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: a FMRI study. PLoS One 7:e46541–e46541. https://doi.org/10.1371/journal.pone.0046541
Article CAS PubMed PubMed Central Google Scholar
Manes JL, Tjaden K, Parrish T, Simuni T, Roberts A, Greenlee JD, Corcos DM, Kurani AS (2018) Altered resting-state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson’s disease. Brain Behav 8(9):e01073. https://doi.org/10.1002/brb3.1073
Article PubMed PubMed Central Google Scholar
Mekyska J, Janousova E, Gomez-Vilda P, Smekal Z, Rektorova I, Eliasova I, Kostalova M, Mrackova M, Alonso-Hernandez JB, Faundez-Zanuy M, López-de-Ipiña K (2015) Robust and complex approach of pathological speech signal analysis. Neurocomputing 167:94–111. https://doi.org/10.1016/j.neucom.2015.02.085
Murphy E, Hoshi K, Benítez-Burraco A (2022) Subcortical syntax: reconsidering the neural dynamics of language. J Neurolinguist 62:101062. https://doi.org/10.1016/j.jneuroling.2022.101062
New AB, Robin DA, Parkinson AL, Eickhoff CR, Reetz K, Hoffstaedter F, Mathys C, Sudmeyer M, Michely J, Caspers J, Grefkes C, Larson CR, Ramig LO, Fox PT, Eickhoff SB (2015) The intrinsic resting state voice network in Parkinson’s disease. Hum Brain Mapp 36:1951–1962. https://doi.org/10.1002/hbm.22748
Article PubMed PubMed Central Google Scholar
Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53–83. https://doi.org/10.1016/S0301-0082(02)00011-4
Article CAS PubMed Google Scholar
Nutt JG, Carter JH, Van Houten L, Woodward WR (1997) Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann Neurol 42:349–355. https://doi.org/10.1002/ana.410420311
Article CAS PubMed Google Scholar
Pichon S, Kell CA (2013) Affective and sensorimotor components of emotional prosody generation. J Neurosci 33:1640. https://doi.org/10.1523/JNEUROSCI.3530-12.2013
Article CAS PubMed PubMed Central Google Scholar
Rektorová I (2010) Effects of dopamine agonists on neuropsychiatric symptoms of Parkinson’s disease. Neurodegener Dis 7:206–209. https://doi.org/10.1159/000295665
Article CAS PubMed Google Scholar
Rektorová I, Rektor I, Bareš M, Dostál V, Ehler E, Fanfrdlová Z, Fiedler J, Klajblová H, Kulišt’ák P, Ressner P, Svátová J, Urbánek K, Velísková J (2005) Cognitive performance in people with Parkinson’s disease and mild or moderate depression: effects of dopamine agonists in an add-on to l-dopa therapy. Eur J Neurol 12:9–15. https://doi.org/10.1111/j.1468-1331.2004.00966.x
Rektorova I, Barrett J, Mikl M, Rektor I, Paus T (2007) Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson’s disease. Mov Disord 22:2043–2051. https://doi.org/10.1002/mds.21548
Rektorova I, Mekyska J, Janousova E, Kostalova M, Eliasova I, Mrackova M, Berankova D, Necasova T, Smekal Z, Marecek R (2016) Speech prosody impairment predicts cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 29:90–95. https://doi.org/10.1016/j.parkreldis.2016.05.018
Rusz J, Tykalová T, Klempíř J, Čmejla R, Růžička E (2016) Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. J Neural Transm 123:379–387. https://doi.org/10.1007/s00702-016-1515-8
Article CAS PubMed Google Scholar
Rusz J, Tykalova T, Novotny M, Zogala D, Sonka K, Ruzicka E, Dusek P (2021) Defining speech subtypes in de novo Parkinson disease. Neurology 97:e2124. https://doi.org/10.1212/WNL.0000000000012878
Article CAS PubMed Google Scholar
Rusz J, Tykalová T, Novotný M, Zogala D, Růžička E, Dušek P (2022) Automated speech analysis in early untreated Parkinson’
Comments (0)